According to research reviewed by Gram, naringin, a natural compound found in citrus fruits like grapefruit, lowered blood sugar and reduced liver inflammation and oxidative stress in diabetic rats over 45 days in a 2026 study. These results come from animal experiments, so benefits for people with diabetes have not yet been established.
A 2026 study published in Archives of Physiology and Biochemistry tested naringin, a natural compound found in citrus fruits like grapefruit, in rats with diabetes. According to research reviewed by Gram, the rats that received naringin for 45 days had lower blood sugar and higher insulin levels than untreated diabetic rats. Their livers also showed less oxidative stress, which is a type of cell damage caused by unstable molecules, and less inflammation. Their liver and pancreas tissue looked healthier under the microscope. The researchers compared naringin with glibenclamide, a standard diabetes medicine. Because this work was done in animals, it cannot yet tell us whether naringin would work the same way in people. Still, the results point to a possible role for citrus compounds in protecting the liver from diabetes-related damage, and they justify further testing in humans.
Key Statistics
A 2026 animal study published in Archives of Physiology and Biochemistry found that naringin, a compound from citrus fruits, significantly reduced blood glucose levels in diabetic rats after 45 days of treatment.
In the same 2026 rat study, naringin increased plasma insulin levels and improved the body’s natural antioxidant defenses in the liver compared with untreated diabetic rats.
The 2026 study reported that naringin reduced inflammation-related markers, including NF-κB p65, TNF-α, and IL-6, at both the gene and protein level in diabetic rats.
The Quick Take
- What they studied: Scientists wanted to know whether naringin, a plant compound from citrus fruits, could lower blood sugar, calm inflammation, and protect the liver and pancreas in rats with diabetes caused by a high-fat diet and a low dose of a diabetes-triggering chemical.
- Who participated: The participants were laboratory rats, not people. Some rats were fed a high-fat diet and others were given a small dose of streptozotocin, a chemical that damages insulin-producing cells. The exact number of rats was not stated in the summary provided.
- Key finding: Rats that received naringin for 45 days had lower blood sugar and higher insulin levels than diabetic rats that did not receive it. Their livers also showed less cell damage from unstable molecules and less inflammation, and their liver and pancreas tissue looked healthier.
- What it means for you: These results are promising but come from animal research. They do not show that eating grapefruit or taking naringin supplements will help people with diabetes. Anyone with diabetes should keep following their doctor’s treatment plan and talk with a healthcare provider before trying any supplement.
The Research Details
The researchers used rats that were made diabetic in two ways. One group ate a high-fat diet, which can lead to insulin resistance, a condition where the body does not respond well to insulin. The other group received a low dose of streptozotocin, a chemical that harms the cells in the pancreas that make insulin. Both methods are common ways to create diabetes-like conditions in rats for laboratory study.
After diabetes was established, the rats were given naringin or glibenclamide, a standard diabetes medicine, for 45 days. The team then measured blood sugar, blood insulin levels, and how well the rats handled insulin. They also checked the liver for signs of cell damage from unstable molecules, measured the body’s natural defense systems against those molecules, and tested levels of inflammation-related substances. Finally, they examined thin slices of liver and pancreas tissue under a microscope.
This type of design lets scientists control the diet, the dose, and the timing very precisely, which is hard to do in human studies. It helps reveal how a compound might work inside the body. However, animal studies do not always predict results in people, so this approach is best seen as an early step.
Testing a compound in animals with diabetes-like conditions allows researchers to watch changes in blood, organs, and tissues over time. Measuring several things at once, such as blood sugar, insulin, liver damage, and tissue structure, gives a more complete picture of what naringin may be doing. Comparing naringin with a standard medicine also shows how it stacks up against an existing treatment, at least in this model.
The study was published in a peer-reviewed scientific journal, which means other experts reviewed it before publication. It measured many outcomes using both blood tests and tissue examination, which strengthens the findings. However, the summary provided does not report the number of rats per group, the exact amounts of naringin given, or the statistical details behind the results, so the strength of the evidence is hard to fully judge. The journal’s impact factor was not verified for this summary.
What the Results Show
The most consistent result was that naringin lowered blood sugar in diabetic rats. Diabetes in these animals caused high blood sugar, and rats that received naringin showed a significant reduction. This matters because high blood sugar over time damages nerves, blood vessels, and organs, so a compound that helps bring it down could be valuable if the effect holds in people.
Naringin also increased plasma insulin levels. Insulin is the hormone that moves sugar from the blood into cells for energy. When insulin is low or the body does not respond to it well, blood sugar stays high. The rise in insulin suggests naringin may help the body’s blood sugar control system work better, though the study summary does not explain exactly how.
The liver findings were also notable. Diabetes increased lipid peroxidation, a form of cell damage in which fats are harmed by unstable molecules. Naringin reduced this damage and improved the body’s own antioxidant defenses, which are natural systems that neutralize those unstable molecules. The researchers also reported that naringin reduced the activity of inflammation-related genes and proteins, including NF-κB p65, TNF-α, and IL-6. These substances help drive chronic inflammation, which is linked to liver disease in people with diabetes.
Finally, the microscope images showed that liver and pancreas tissue looked better in naringin-treated rats. Damaged tissue structure is a sign of ongoing harm, so these visible improvements support the idea that the compound protected the organs, not just changed blood numbers.
Naringin performed in ways the researchers described as comparable to glibenclamide in some measures, though the summary does not provide full comparison numbers. The study also suggests that naringin’s effects may come from several connected actions at once: lowering blood sugar, calming inflammation, and reducing oxidative stress. This combined action is one reason scientists are interested in plant compounds like naringin, which are often studied for their broad effects on the body.
Naringin is a flavonoid, a family of plant compounds found in many fruits, vegetables, and teas. Previous laboratory and animal studies have linked flavonoids like naringin to lower blood sugar, reduced inflammation, and antioxidant effects. This 2026 study adds to that body of work by focusing specifically on the liver and pancreas in rats with two different types of diabetes-like conditions. Human studies of citrus flavonoids have been more mixed and generally smaller, so this animal evidence should be viewed as a starting point rather than a final answer.
The most important limitation is that the study was done in rats, and results in animals do not always carry over to people. Rats also process compounds differently from humans, and the doses used in laboratory research may not match what a person could safely or realistically take from food or supplements. The summary also does not give the number of rats, the exact dose of naringin, or how long the benefits lasted after treatment ended. Finally, the study did not test whole citrus fruit, so it cannot tell us what eating grapefruit or oranges would do.
The Bottom Line
Based on this single animal study, the evidence is early and preliminary. Confidence is low that naringin would have the same effects in people, but the results give a reasonable reason to study it further in clinical trials. People with diabetes should not replace prescribed medicines with naringin or citrus extracts based on this research. Confidence is higher that a balanced diet with whole fruits, including citrus, supports overall health, but this study does not prove that such foods treat diabetes.
People with diabetes, prediabetes, or fatty liver concerns may find this research interesting, along with researchers and healthcare professionals who follow nutrition science. People who take diabetes medicine should be especially careful, since the study does not address how naringin might interact with medications. Healthy adults who simply enjoy citrus fruit do not need to change anything based on this study. Anyone considering a naringin supplement should speak with a doctor or pharmacist first.
Animal studies like this one typically take many months to years before results could reach human testing, and human trials can take several more years to show whether a compound is safe and effective. Even in this rat study, the treatment lasted 45 days. Anyone hoping to see changes in blood sugar or liver health from diet should expect gradual progress over weeks to months and should track results with a healthcare provider.
Frequently Asked Questions
Does naringin lower blood sugar?
In a 2026 study of diabetic rats, naringin significantly reduced blood glucose levels over 45 days and raised plasma insulin levels. These results come from animal research, so it is not yet known whether the same effect occurs in people with diabetes.
What foods contain naringin?
Naringin is a flavonoid found mainly in citrus fruits, especially grapefruit, pomelo, and bitter oranges. The 2026 rat study did not test whole fruit, so eating citrus cannot be assumed to produce the same effects seen in the laboratory.
Can naringin protect the liver in people with diabetes?
Research in diabetic rats found that naringin reduced liver oxidative stress and inflammation and improved liver tissue structure. Scientists have not confirmed these liver benefits in humans, so anyone with diabetes should consult a doctor before using naringin supplements.
Is naringin safe to take with diabetes medicine?
The 2026 rat study tested naringin alongside glibenclamide, a standard diabetes drug, but the summary does not report safety or interaction data. Anyone taking diabetes medication should check with a doctor or pharmacist before adding any citrus extract supplement.
Want to Apply This Research?
- Log fasting blood sugar readings and any citrus servings in the app each day, noting the portion size, such as one half grapefruit or one medium orange. Review the weekly average of fasting blood sugar alongside citrus intake to spot patterns over several weeks. Record any changes in medications or supplements so that shifts in blood sugar can be understood in context.
- Add a whole citrus fruit, such as an orange or half a grapefruit, to your daily meal plan as part of a balanced diet, and check with your doctor first if you take diabetes medicine because grapefruit can interact with some drugs. Pair it with vegetables, whole grains, and lean protein to support stable blood sugar. Use the app to set a reminder for meals and to log what you eat so you can see how choices affect your numbers.
- Track fasting blood sugar, weight, and waist measurements at consistent intervals, such as weekly for blood sugar and monthly for body measurements. Review trends every three months with a healthcare provider, especially before making any change to diet or supplements. Keep notes on energy levels, appetite, and any side effects so that changes can be discussed with a doctor.
This article summarizes an animal study in rats and is for general education only. Results in rats do not confirm that naringin, grapefruit, or any citrus product will help or harm people with diabetes or liver conditions. Do not change diabetes medicine, diet, or supplement use without first talking with a qualified healthcare provider, especially if you take prescription medications.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.